Collecting data on chronic viral hepatitis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather and analyze clinical data from patients suffering from chronic viral hepatitis to understand their long-term outcomes better. By utilizing real-world evidence, the study seeks to identify the characteristics of these patients and optimize treatment strategies accordingly. Chronic viral hepatitis can lead to severe liver complications, and this research addresses the gap in high-quality evidence regarding its management. The study will involve patients who have shown persistent viral infection for over six months.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Informed consent of patients.
2. Evidence of persistent virus infection for greater than six months \[hepatitis C virus(HCV) RNA positive, hepatitis B surface antigen(HBsAg) or hepatitis B virus(HBV) DNA positive\]

Exclusion Criteria:

1. Serious psychiatric history, especially depression.

   * Severe mental illness is defined as major depression or psychosis, suicide attempts, hospitalization due to mental illness or a period of disability due to mental illness.
2. Patients with serious diseases of heart, lung, kidney, brain, blood and other important organs.
3. Patients with malignant tumors (excluding those cured).

Where it's running

• Huashan Hospital
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Yiqi Yu, Doctor
• Email: yyq19890619@126.com
• Phone: 13601637563

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Short-Course TB Treatment for Children with Non-Severe Pulmonary TB

  This trial tests two shorter-treatment options for kids with non-severe pulmonary TB to see if they can clear the infection as well as the standard 6-month plan.

  Recruiting at 13 sites Phase 2 Huashan Hospital · Fuzhou, Fujian and 12 other locations · NCT07893444

• Niaoduqing Granules for Older Adults with Kidney Function Decline

  This study tests whether Niaoduqing Granules can slow kidney decline and improve nutrition and frailty in adults over 60 with non-dialysis chronic kidney disease.

  Recruiting Phase 4 Huashan Hospital · Shanghai, Shanghai Municipality · NCT07741292

• Enarodustat for Anemia in Non-Dialysis CKD Patients

  This study tests whether enarodustat can help increase hemoglobin safely in adults with CKD who aren’t on dialysis, grouping participants by inflammation level.

  Recruiting Huashan Hospital · Shanghai, Shanghai Municipality · NCT07741279

• Gastric and pancreatic cancer patients see if IR199 with Ga-68 and I-131 is safe and how it distributes in the body

  This study tests the safety and how the radio-labeled IR199 distributes in the body of adults with Claudin 18.2-positive gastric or pancreatic cancer.

  Recruiting Early Phase 1 Huashan Hospital · Shanghai · NCT07707531

• Clinical Multimodal Surveillance of Respiratory Pathogens

  This nationwide study tests a hospital-based system to track respiratory pathogens in patients with respiratory symptoms and to use samples collected during care to spot trends and support prevention efforts.

  Recruiting at 31 sites Huashan Hospital · Beijing, Beijing Municipality and 30 other locations · NCT07694648

• Infection and Immune Aging in Older Adults: A Look at How Immunosenescence Relates to Infections

  This study will follow people aged 60 and up to see how aging immune systems relate to infections, comparing healthy seniors with those who have infections.

  Recruiting Huashan Hospital · Shanghai, Shanghai Municipality · NCT07672522

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.